Pentergot, a new agent for the symptomatic treatment of migraine.
D001463:Barbiturates / Q000627:therapeutic use*; D002110:Caffeine / Q000627:therapeutic use*; D002317:Cardiovascular Agents; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000628:therapy*
D001463:Barbiturates; D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D002110:Caffeine
BARBITURATES/therapeutic use; CAFFEINE/therapeutic use; ERGOT ALKALOIDS/therapeutic use; MIGRAINE/therapy